SCHEMBL18958654

SCHEMBL18958654

OB(O)c1cccc2c1c1ccccc1n2-c1cc(-c2ccccc2)nc(-c2ccccc2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ ATM Q13315 1/20 0.36
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ PDE10A Q9Y233 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ PLAUR Q03405 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ AHR P35869 1/20 0.33
▸ NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17349641 0.90 ADORA3 (0.37) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL17349636 0.90 ADORA3 (0.37) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL18958656 0.90 COMT (0.36) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL18958659 0.89 ADORA3 (0.36) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL18958652 0.88 MEN1 (0.43) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL18958653 0.88 MEN1 (0.38) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL17349637 0.88 MEN1 (0.43) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL17339040 0.87 KDM4E (0.37) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL18958661 0.87 MEN1 (0.39) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL18958294 0.85 KDM4E (0.36) KDM4EL3MBTL1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170170407-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2017-06-15 — — US disclosed
US-20170170407-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2017-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170407-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF OR10J3, OR51E2, ETV6 KDM4E 148/4885L3MBTL1 1793/4885ATM 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback